BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghasemiyeh P, Borhani-Haghighi A, Karimzadeh I, Mohammadi-Samani S, Vazin A, Safari A, Qureshi AI. Major Neurologic Adverse Drug Reactions, Potential Drug-Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review. Ther Clin Risk Manag 2020;16:595-605. [PMID: 32669846 DOI: 10.2147/TCRM.S259152] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Ghasemiyeh P, Mohammadi-Samani S. COVID-19 outbreak: Challenges in pharmacotherapy based on pharmacokinetic and pharmacodynamic aspects of drug therapy in patients with moderate to severe infection. Heart Lung 2020;49:763-73. [PMID: 32980626 DOI: 10.1016/j.hrtlng.2020.08.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Ghasemiyeh P, Mohammadi-samani S, Firouzabadi N, Vazin A, Zand F. A brief ICU residents’ guide: Pharmacotherapy, pharmacokinetic aspects and dose adjustments in critically ill adult patients admitted to ICU. Trends in Anaesthesia and Critical Care 2021;41:11-31. [DOI: 10.1016/j.tacc.2021.05.004] [Reference Citation Analysis]
3 Duyan M, Ozturan IU. Acute Psychosis in COVID-19: Is It Due to Favipiravir Treatment or Acute Viral Illness? SN Compr Clin Med 2021;:1-3. [PMID: 33997622 DOI: 10.1007/s42399-021-00952-x] [Reference Citation Analysis]
4 Zarkesh K, Entezar-Almahdi E, Ghasemiyeh P, Akbarian M, Bahmani M, Roudaki S, Fazlinejad R, Mohammadi-Samani S, Firouzabadi N, Hosseini M, Farjadian F. Drug-based therapeutic strategies for COVID-19-infected patients and their challenges. Future Microbiol 2021;16:1415-51. [PMID: 34812049 DOI: 10.2217/fmb-2021-0116] [Reference Citation Analysis]
5 Martinotti G, Bonanni L, Barlati S, Miuli A, Sepede G, Prestia D, Trabucco A, Palumbo C, Massaro A, Olcese M, D'Ardes D, Cipollone F, Amore M, Bondi E, Russo M, Carrarini C, Onofrj M, Sensi SL, Vita A, di Giannantonio M. Delirium in COVID-19 patients: a multicentric observational study in Italy. Neurol Sci 2021. [PMID: 34318364 DOI: 10.1007/s10072-021-05461-2] [Reference Citation Analysis]
6 Fernando EZ, Yu JRT, Santos SMA, Jamora RDG. Involuntary Movements Following Administration of Hydroxychloroquine for COVID-19 Pneumonia. J Mov Disord 2021;14:75-7. [PMID: 33278866 DOI: 10.14802/jmd.20091] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Aghayari Sheikh Neshin S, Shahjouei S, Koza E, Friedenberg I, Khodadadi F, Sabra M, Kobeissy F, Ansari S, Tsivgoulis G, Li J, Abedi V, Wolk DM, Zand R. Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology. Front Cardiovasc Med 2021;8:649922. [PMID: 33855053 DOI: 10.3389/fcvm.2021.649922] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Arjmand B, Roudsari PP, Alavi-Moghadam S, Rezaei-Tavirani M, Tayanloo-Beik A, Mehrdad N, Adibi H, Larijani B. Potential for Stem Cell-Based Therapy in the Road of Treatment for Neurological Disorders Secondary to COVID-19. Regen Eng Transl Med 2021;:1-15. [PMID: 34746370 DOI: 10.1007/s40883-021-00234-x] [Reference Citation Analysis]
9 Cattaneo D, Pasina L, Maggioni AP, Giacomelli A, Oreni L, Covizzi A, Bradanini L, Schiuma M, Antinori S, Ridolfo A, Gervasoni C. Drug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy. Drugs Aging 2020;37:925-33. [PMID: 33150470 DOI: 10.1007/s40266-020-00812-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
10 Kaur RJ, Charan J, Dutta S, Sharma P, Bhardwaj P, Sharma P, Lugova H, Krishnapillai A, Islam S, Haque M, Misra S. Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database. Infect Drug Resist 2020;13:4427-38. [PMID: 33364790 DOI: 10.2147/IDR.S287934] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
11 Ersoy İ, Ersoy P. Impact of drug interactions with direct oral anticoagulants on mortality in elderly with atrial fibrillation during the COVID-19 pandemic. Medicina Clínica 2022. [DOI: 10.1016/j.medcli.2022.05.009] [Reference Citation Analysis]
12 Alavian G, Kolahdouzan K, Mortezazadeh M, Torabi ZS. Antiretrovirals for Prophylaxis Against COVID-19: A Comprehensive Literature Review. J Clin Pharmacol 2021;61:581-90. [PMID: 33217030 DOI: 10.1002/jcph.1788] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
13 Thomas L, Birangal SR, Ray R, Sekhar Miraj S, Munisamy M, Varma M, S V CS, Banerjee M, Shenoy GG, Rao M. Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational techniques data. Ther Adv Drug Saf 2021;12:20420986211041277. [PMID: 34471515 DOI: 10.1177/20420986211041277] [Reference Citation Analysis]
14 Manera MR, Fiabane E, Pain D, Aiello EN, Radici A, Ottonello M, Padovani M, Wilson BA, Fish J, Pistarini C. Clinical features and cognitive sequelae in COVID-19: a retrospective study on N=152 patients. Neurol Sci 2021. [PMID: 34779965 DOI: 10.1007/s10072-021-05744-8] [Reference Citation Analysis]
15 Ghasemiyeh P, Mohammadi-Samani S, Firouzabadi N, Dehshahri A, Vazin A. A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines. Int Immunopharmacol 2021;100:108162. [PMID: 34562844 DOI: 10.1016/j.intimp.2021.108162] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Borah P, Deb PK, Chandrasekaran B, Goyal M, Bansal M, Hussain S, Shinu P, Venugopala KN, Al-Shar'i NA, Deka S, Singh V. Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted. Front Mol Biosci 2021;8:627723. [PMID: 33681293 DOI: 10.3389/fmolb.2021.627723] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Finsterer J. Putative mechanisms explaining neuro-COVID. J Neuroimmunol 2020;350:577453. [PMID: 33333470 DOI: 10.1016/j.jneuroim.2020.577453] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Finsterer J, Scorza FA. Perspectives of Neuro-COVID: Myasthenia. Front Neurol 2021;12:635747. [PMID: 33732209 DOI: 10.3389/fneur.2021.635747] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ghasemiyeh P, Mohammadi-Samani S. The necessity of early anti-inflammatory therapy initiation in cases with mild-to-moderate COVID-19: A personal experience from an attending pharmacist and his resident. Acta Biomed 2021;92:e2021250. [PMID: 34212899 DOI: 10.23750/abm.v92i3.11683] [Reference Citation Analysis]
20 Finsterer J, Scorza FA. Clinical and Pathophysiologic Spectrum of Neuro-COVID. Mol Neurobiol 2021;58:3787-91. [PMID: 33829393 DOI: 10.1007/s12035-021-02383-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]